| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |